Videndum (VID) H2 2023 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2023 earnings summary
31 Oct, 2026Executive summary
FY 2023 was exceptionally challenging: continuing-operations revenue fell 31% YoY amid strikes, destocking and weak macroeconomic conditions.
Adjusted operating profit fell 81% to £12.8m; cost reductions and an equity raise helped mitigate pressures and support liquidity.
The Board expects a strong H2 2024 recovery as cine and scripted TV markets gradually improve, while noting recovery timing and pace remain uncertain.
Financial highlights
Continuing-operations revenue was £306.9m versus £442.5m in FY 2022; gross profit was £118.8m versus £193.4m.
Adjusted operating profit was £12.8m versus £66.2m; PBT was £1.3m versus £60.2m.
EPS was 8.5p versus 96.8p; no dividend was declared for FY 2023.
Adjusted operating expenses fell 17% to £106.0m, supported by self-help measures and site-rationalisation synergies.
Adjusted free cash flow was an outflow of £23.8m versus an inflow of £40.3m in FY 2022.
Outlook and guidance
Cine and scripted TV recovery, initially anticipated in March, is now expected from June; Q1 trading was below expectations as recovery was delayed.
The Board expects a strong H2 2024 recovery, with Summer Olympics and US election activity supporting broadcast TV performance.
At 31 March 2024, net debt was £122.4m and leverage 3.0x, within the 4.25x covenant limit; target leverage remains below 1.5x.
Cost, capital expenditure and working capital controls remain priorities as trading conditions improve.
Latest events from Videndum
- FY26 outlook reset to FY25 levels as a self-help programme targets ~£10m annualised savings.VID
Trading update - Adjusted EBITDA rose to £3.0m and net debt fell by £103m amid operational and market challenges.VID
H1 2026 - New CEO appointed; H1 2026 trading steady, but full-year EBITDA guidance reduced.VID
Trading update - Revenue fell 19% and net debt rose, but refinancing and disposals improved financial stability.VID
H2 2025 - Order intake and EBITDA improved in Q3, with deleveraging talks and FY26 outlook steady.VID
Trading Update - Revenue down 25% YoY; cost savings and new products support recovery amid uncertainty.VID
H1 2025 - FY24 revenue to reach £280m amid restructuring, with market recovery expected in H1 FY25.VID
Trading Update - Revenue down 7% year-over-year, but cash flow and cost controls support a 2025 recovery.VID
H1 2024 - Revenue down 8% and £147m loss, but cost savings and refinancing support future recovery.VID
H2 2024